speb/financial-data huggingface dataset:
CURI cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -757000.00
CURI cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 2058000.00
CURI cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 3000.00
CURI cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -479000.00
CURI cash_flow (quarterly, 2025-03-31) — Change In Payable: -757000.00
CURI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1301000.00
CURI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -1619000.00
CURI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -794000.00
CURI cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -1619000.00
CURI cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1357000.00
CURI balance_sheet (quarterly, 2025-03-31) — Common Stock: 5000.00
CURI cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -2277000.00
CURI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 58116000.00
CURI cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CURI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 7080000.00
CURI balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 3373000.00
CURI balance_sheet (quarterly, 2025-03-31) — Current Assets: 42525000.00
CURI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 404000.00
CURI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 404000.00
CURI balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 10509000.00
CURI balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 10509000.00
CURI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 22774000.00
CURI cash_flow (quarterly, 2025-03-31) — Depreciation: 41000.00
CURI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3554000.00
CURI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3554000.00
CURI balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 96000.00
CURI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 57132000.00
CURI income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.01
CURI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 319000.00
CURI balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 0.00
CURI income_statement (quarterly, 2025-03-31) — EBIT: 79000.00
CURI income_statement (quarterly, 2025-03-31) — EBITDA: 3633000.00
CURI income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -151000.00
CURI cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 151000.00
CURI cash_flow (quarterly, 2025-03-31) — End Cash Position: 9308000.00
CURI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -2635000.00
CURI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 1845000.00
CURI cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 8000.00
CURI income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -7000.00
CURI income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4997000.00
CURI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 29826000.00
CURI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3475000.00
CURI income_statement (quarterly, 2025-03-31) — Gross Profit: 8010000.00
CURI balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 5485000.00
CURI cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 34000.00
CURI income_statement (quarterly, 2025-03-31) — Interest Income: 426000.00
CURI income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 426000.00
CURI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 58116000.00
CURI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 2070000.00
CURI balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 5485000.00
CURI balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 9182000.00
CURI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 3783000.00
CURI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3783000.00
CURI balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 3697000.00
CURI cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CURI income_statement (quarterly, 2025-03-31) — Net Income: 319000.00
CURI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 319000.00
CURI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 319000.00
CURI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 319000.00
CURI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 319000.00
CURI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 319000.00
CURI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 319000.00
CURI income_statement (quarterly, 2025-03-31) — Net Interest Income: 426000.00
CURI cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 2147000.00
CURI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 426000.00
CURI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -358000.00
CURI balance_sheet (quarterly, 2025-03-31) — Net PPE: 3475000.00
CURI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -77000.00
CURI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 28290000.00
CURI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3640000.00
CURI income_statement (quarterly, 2025-03-31) — Normalized Income: 325435.16
CURI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 1922000.00
CURI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 159000.00
CURI income_statement (quarterly, 2025-03-31) — Operating Income: 79000.00
CURI income_statement (quarterly, 2025-03-31) — Operating Revenue: 14692000.00
CURI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 56930110.00
CURI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1233000.00
CURI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2835000.00
CURI income_statement (quarterly, 2025-03-31) — Other Gand A: 1502000.00
CURI income_statement (quarterly, 2025-03-31) — Other Income Expense: -158000.00
CURI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 29826000.00
CURI cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1984000.00
CURI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 244000.00
CURI balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 483000.00
CURI balance_sheet (quarterly, 2025-03-31) — Other Properties: 3475000.00
CURI balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 24262000.00
CURI balance_sheet (quarterly, 2025-03-31) — Payables: 5653000.00
CURI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 9026000.00
CURI income_statement (quarterly, 2025-03-31) — Pretax Income: 347000.00
CURI cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -6253000.00
CURI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -77000.00
CURI balance_sheet (quarterly, 2025-03-31) — Receivables: 7722000.00
CURI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 7080000.00
CURI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3554000.00
CURI cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CURI balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 125000.00
CURI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -308957000.00
CURI income_statement (quarterly, 2025-03-31) — Salaries And Wages: 3495000.00
CURI cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 8400000.00
CURI income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 2934000.00
CURI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7931000.00
CURI balance_sheet (quarterly, 2025-03-31) — Share Issued: 57146000.00
CURI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 863000.00
CURI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 58116000.00
CURI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 28290000.00
CURI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -564.84
CURI income_statement (quarterly, 2025-03-31) — Tax Provision: 28000.00
CURI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.08
CURI balance_sheet (quarterly, 2025-03-31) — Total Assets: 85252000.00
CURI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 58116000.00
CURI balance_sheet (quarterly, 2025-03-31) — Total Debt: 4187000.00
CURI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 58116000.00
CURI income_statement (quarterly, 2025-03-31) — Total Expenses: 15011000.00
CURI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 27136000.00
CURI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 42727000.00
CURI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4362000.00
CURI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 79000.00
CURI balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 878000.00
CURI income_statement (quarterly, 2025-03-31) — Total Unusual Items: -7000.00
CURI income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -7000.00
CURI balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 215890.00
CURI balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 251000.00
CURI balance_sheet (quarterly, 2025-03-31) — Working Capital: 19751000.00
CURI income_statement (quarterly, 2025-06-30) — +Operating Expense: 9668000.00
CURI income_statement (quarterly, 2025-06-30) — +Total Revenue: 19012000.00
CURI balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4964000.00
CURI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 11354000.00
CURI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 368648000.00
CURI cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 3600000.00
CURI cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 3600000.00
CURI cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -159000.00
CURI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 57585000.00
CURI income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
CURI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 9308000.00
CURI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4090000.00
CURI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5000.00
CURI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6943000.00
CURI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 28133000.00
CURI cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -10388000.00
CURI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -11327000.00
CURI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 6233000.00
CURI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 2789000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 236000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1965000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 332000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -897000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Payable: 236000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 2201000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Receivables: -3632000.00
CURI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1996000.00
CURI cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -3632000.00
CURI cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2305000.00
CURI balance_sheet (quarterly, 2025-06-30) — Common Stock: 5000.00
CURI cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -10388000.00
CURI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 49841000.00
CURI cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CURI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8864000.00
CURI balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 7545000.00
CURI balance_sheet (quarterly, 2025-06-30) — Current Assets: 40456000.00
CURI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 412000.00
CURI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 412000.00
CURI balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 9563000.00
CURI balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 9563000.00
CURI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 24420000.00
CURI cash_flow (quarterly, 2025-06-30) — Depreciation: 42000.00
CURI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3642000.00
CURI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3642000.00
CURI balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 174000.00
CURI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 57585000.00
CURI income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
CURI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 784000.00
CURI balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 0.00
CURI income_statement (quarterly, 2025-06-30) — EBIT: 480000.00
CURI income_statement (quarterly, 2025-06-30) — EBITDA: 4122000.00
CURI income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -156000.00
CURI cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 156000.00
CURI cash_flow (quarterly, 2025-06-30) — End Cash Position: 7003000.00
CURI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -11327000.00
CURI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2789000.00
CURI cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 78000.00
CURI income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -79000.00
CURI income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 6393000.00
CURI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 28577000.00
CURI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3363000.00
CURI income_statement (quarterly, 2025-06-30) — Gross Profit: 10148000.00
CURI balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 2484000.00
CURI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 49841000.00
CURI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 6233000.00
CURI balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2484000.00
CURI balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 6025000.00
CURI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 3678000.00
CURI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3678000.00
CURI balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 3541000.00
CURI cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CURI income_statement (quarterly, 2025-06-30) — Net Income: 784000.00
CURI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 784000.00
CURI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 784000.00
CURI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 784000.00
CURI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 784000.00
CURI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 784000.00
CURI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 784000.00
CURI income_statement (quarterly, 2025-06-30) — Net Interest Income: 424000.00
CURI cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 6233000.00
CURI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 424000.00
CURI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -939000.00
CURI balance_sheet (quarterly, 2025-06-30) — Net PPE: 3363000.00
CURI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
CURI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21264000.00
CURI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 4201000.00
CURI income_statement (quarterly, 2025-06-30) — Normalized Income: 846410.00
CURI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2789000.00
CURI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 234000.00
CURI income_statement (quarterly, 2025-06-30) — Operating Income: 480000.00
CURI income_statement (quarterly, 2025-06-30) — Operating Revenue: 18644000.00
CURI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 57711000.00
CURI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 909000.00
CURI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1024000.00
CURI income_statement (quarterly, 2025-06-30) — Other Gand A: 1722000.00
CURI income_statement (quarterly, 2025-06-30) — Other Income Expense: -235000.00
CURI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 28577000.00
CURI cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1930000.00
CURI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 231000.00
CURI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 539000.00
CURI balance_sheet (quarterly, 2025-06-30) — Other Properties: 3363000.00
CURI balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 21190000.00
CURI balance_sheet (quarterly, 2025-06-30) — Payables: 5876000.00
CURI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13421000.00
CURI income_statement (quarterly, 2025-06-30) — Pretax Income: 669000.00
CURI cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -4817000.00
CURI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
CURI balance_sheet (quarterly, 2025-06-30) — Receivables: 11354000.00
CURI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8864000.00
CURI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3642000.00
CURI cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CURI balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 60000.00
CURI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -318561000.00
CURI income_statement (quarterly, 2025-06-30) — Salaries And Wages: 4671000.00
CURI cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 11050000.00
CURI income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 3275000.00
CURI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 9668000.00
CURI balance_sheet (quarterly, 2025-06-30) — Share Issued: 57926890.00
CURI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2214000.00
CURI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 49841000.00
CURI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 21264000.00
CURI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -16590.00
CURI income_statement (quarterly, 2025-06-30) — Tax Provision: -115000.00
CURI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CURI balance_sheet (quarterly, 2025-06-30) — Total Assets: 78652000.00
CURI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 49841000.00
CURI balance_sheet (quarterly, 2025-06-30) — Total Debt: 4090000.00
CURI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 49841000.00
CURI income_statement (quarterly, 2025-06-30) — Total Expenses: 18532000.00
CURI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 28811000.00
CURI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 38196000.00
CURI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 4391000.00
CURI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 480000.00
CURI income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -424000.00
CURI balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 912000.00
CURI income_statement (quarterly, 2025-06-30) — Total Unusual Items: -79000.00
CURI income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -79000.00
CURI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 215890.00
CURI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 251000.00
CURI balance_sheet (quarterly, 2025-06-30) — Working Capital: 16036000.00
CURI income_statement (quarterly, 2025-09-30) — +Operating Expense: 15262000.00
CURI income_statement (quarterly, 2025-09-30) — +Total Revenue: 18359000.00
CURI balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2866000.00
CURI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 9201000.00
CURI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 374499000.00
CURI cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 3583000.00
CURI cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 3583000.00
CURI cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -100000.00
CURI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 57930000.00
CURI income_statement (quarterly, 2025-09-30) — Basic EPS: -0.06
CURI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 7003000.00
CURI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3990000.00
CURI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 5000.00
CURI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 14108000.00
CURI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 27780000.00
CURI cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -4646000.00
CURI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -5825000.00
CURI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 8613000.00
CURI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 4377000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -2267000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 2477000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -79000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1307000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Payable: -2267000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 210000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Receivables: 2153000.00
CURI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 977000.00
CURI cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 2153000.00
CURI cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7165000.00
CURI balance_sheet (quarterly, 2025-09-30) — Common Stock: 5000.00
CURI cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -4646000.00
CURI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 47194000.00
CURI cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CURI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 7588000.00
CURI balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 9469000.00
CURI balance_sheet (quarterly, 2025-09-30) — Current Assets: 38040000.00
CURI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 420000.00
CURI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 420000.00
CURI balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 8277000.00
CURI balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 8277000.00
CURI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 23494000.00
CURI cash_flow (quarterly, 2025-09-30) — Depreciation: 39000.00
CURI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3622000.00
CURI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3622000.00
CURI balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 0.00
CURI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 57930000.00
CURI income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.06
CURI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -3744000.00
CURI balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 108000.00
CURI income_statement (quarterly, 2025-09-30) — EBIT: -4491000.00
CURI income_statement (quarterly, 2025-09-30) — EBITDA: -869000.00
CURI income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 76000.00
CURI cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -76000.00
CURI cash_flow (quarterly, 2025-09-30) — End Cash Position: 14168000.00
CURI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -5825000.00
CURI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 4377000.00
CURI cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -174000.00
CURI income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 174000.00
CURI income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 11820000.00
CURI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 28091000.00
CURI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3254000.00
CURI income_statement (quarterly, 2025-09-30) — Gross Profit: 10771000.00
CURI balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 1488000.00
CURI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 47194000.00
CURI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 8613000.00
CURI balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 1488000.00
CURI balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 5105000.00
CURI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3570000.00
CURI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3570000.00
CURI balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 3617000.00
CURI cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CURI income_statement (quarterly, 2025-09-30) — Net Income: -3744000.00
CURI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -3744000.00
CURI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -3744000.00
CURI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -3744000.00
CURI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -3744000.00
CURI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3744000.00
CURI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -3744000.00
CURI income_statement (quarterly, 2025-09-30) — Net Interest Income: 290000.00
CURI cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 8613000.00
CURI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 290000.00
CURI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1179000.00
CURI balance_sheet (quarterly, 2025-09-30) — Net PPE: 3254000.00
CURI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
CURI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 19103000.00
CURI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1043000.00
CURI income_statement (quarterly, 2025-09-30) — Normalized Income: -3908883.83
CURI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 4377000.00
CURI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -250000.00
CURI income_statement (quarterly, 2025-09-30) — Operating Income: -4491000.00
CURI income_statement (quarterly, 2025-09-30) — Operating Revenue: 18007000.00
CURI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 58081110.00
CURI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 999000.00
CURI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1726000.00
CURI income_statement (quarterly, 2025-09-30) — Other Gand A: 2096000.00
CURI income_statement (quarterly, 2025-09-30) — Other Income Expense: 250000.00
CURI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 28091000.00
CURI cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -3105000.00
CURI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 215000.00
CURI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 447000.00
CURI balance_sheet (quarterly, 2025-09-30) — Other Properties: 3254000.00
CURI balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 13672000.00
CURI balance_sheet (quarterly, 2025-09-30) — Payables: 3602000.00
CURI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 13071000.00
CURI income_statement (quarterly, 2025-09-30) — Pretax Income: -3951000.00
CURI cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -737000.00
CURI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
CURI balance_sheet (quarterly, 2025-09-30) — Receivables: 9201000.00
CURI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 7588000.00
CURI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3622000.00
CURI cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CURI balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 60000.00
CURI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -327059000.00
CURI income_statement (quarterly, 2025-09-30) — Salaries And Wages: 9724000.00
CURI cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 9350000.00
CURI income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 3442000.00
CURI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 15262000.00
CURI balance_sheet (quarterly, 2025-09-30) — Share Issued: 58297000.00
CURI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 6977000.00
CURI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 47194000.00
CURI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 19103000.00
CURI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 9116.17
CURI income_statement (quarterly, 2025-09-30) — Tax Provision: -207000.00
CURI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.05
CURI balance_sheet (quarterly, 2025-09-30) — Total Assets: 74705000.00
CURI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 47194000.00
CURI balance_sheet (quarterly, 2025-09-30) — Total Debt: 3990000.00
CURI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 47194000.00
CURI income_statement (quarterly, 2025-09-30) — Total Expenses: 22850000.00
CURI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 27511000.00
CURI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 36665000.00
CURI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 4017000.00
CURI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4491000.00
CURI income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -290000.00
CURI balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 628000.00
CURI income_statement (quarterly, 2025-09-30) — Total Unusual Items: 174000.00
CURI income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 174000.00
CURI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 215890.00
CURI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 251000.00
CURI balance_sheet (quarterly, 2025-09-30) — Working Capital: 14546000.00
CURI income_statement (annual, 2025-12-31) — +Operating Expense: 47849000.00
CURI income_statement (quarterly, 2025-12-31) — +Operating Expense: 14988000.00
CURI income_statement (annual, 2025-12-31) — +Total Revenue: 71658000.00
CURI income_statement (quarterly, 2025-12-31) — +Total Revenue: 19197000.00
CURI balance_sheet (annual, 2025-12-31) — Accounts Payable: 9449000.00
CURI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 9449000.00
CURI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 8893000.00
CURI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 8893000.00
CURI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1718000.00
CURI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1718000.00
CURI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 377577000.00
CURI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 377577000.00
CURI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -200000.00
CURI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -200000.00
CURI cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 14511000.00
CURI cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 3815000.00
CURI cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 14511000.00
CURI cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 3815000.00
CURI cash_flow (annual, 2025-12-31) — Amortization Of Securities: -517000.00
CURI cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -63000.00
CURI income_statement (annual, 2025-12-31) — Basic Average Shares: 57664000.00
CURI income_statement (annual, 2025-12-31) — Basic EPS: -0.11
CURI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 7951000.00
CURI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 14168000.00
CURI cash_flow (annual, 2025-12-31) — Capital Expenditure: -102000.00
CURI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -25000.00
CURI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 3888000.00
CURI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 3888000.00
CURI balance_sheet (annual, 2025-12-31) — Capital Stock: 5000.00
CURI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5000.00
CURI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 18318000.00
CURI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 18318000.00
CURI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 27284000.00
CURI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 27284000.00
CURI cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -22010000.00
CURI cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -4699000.00
CURI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -25778000.00
CURI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -5991000.00
CURI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 23148000.00
CURI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 6232000.00
CURI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 13057000.00
CURI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 3969000.00
CURI cash_flow (annual, 2025-12-31) — Change In Account Payable: 3795000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 6583000.00
CURI cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 6070000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -430000.00
CURI cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -194000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -450000.00
CURI cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -2617000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 66000.00
CURI cash_flow (annual, 2025-12-31) — Change In Payable: 3795000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Payable: 6583000.00
CURI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 9865000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 6153000.00
CURI cash_flow (annual, 2025-12-31) — Change In Receivables: -2790000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Receivables: 308000.00
CURI cash_flow (annual, 2025-12-31) — Change In Working Capital: 4264000.00
CURI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 6077000.00
CURI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2790000.00
CURI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 308000.00
CURI cash_flow (annual, 2025-12-31) — Changes In Cash: 10427000.00
CURI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4210000.00
CURI balance_sheet (annual, 2025-12-31) — Common Stock: 5000.00
CURI balance_sheet (quarterly, 2025-12-31) — Common Stock: 5000.00
CURI cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -22010000.00
CURI cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -4699000.00
CURI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 41487000.00
CURI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 41487000.00
CURI cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
CURI cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
CURI balance_sheet (annual, 2025-12-31) — Construction In Progress: 0.00
CURI balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 0.00
CURI income_statement (annual, 2025-12-31) — Cost Of Revenue: 31113000.00
CURI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 7581000.00
CURI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 9262000.00
CURI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 9262000.00
CURI balance_sheet (annual, 2025-12-31) — Current Assets: 37435000.00
CURI balance_sheet (quarterly, 2025-12-31) — Current Assets: 37435000.00
CURI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 428000.00
CURI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 428000.00
CURI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 428000.00
CURI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 428000.00
CURI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 8409000.00
CURI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 8409000.00
CURI balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 8409000.00
CURI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 8409000.00
CURI balance_sheet (annual, 2025-12-31) — Current Liabilities: 30314000.00
CURI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 30314000.00
CURI cash_flow (annual, 2025-12-31) — Depreciation: 164000.00
CURI cash_flow (quarterly, 2025-12-31) — Depreciation: 42000.00
CURI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 14675000.00
CURI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3857000.00
CURI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 14675000.00
CURI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3857000.00
CURI balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
CURI balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
CURI income_statement (annual, 2025-12-31) — Diluted Average Shares: 57664000.00
CURI income_statement (annual, 2025-12-31) — Diluted EPS: -0.11
CURI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -6427000.00
CURI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3786000.00
CURI balance_sheet (annual, 2025-12-31) — Dividends Payable: 408000.00
CURI balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 408000.00
CURI income_statement (annual, 2025-12-31) — EBIT: -7304000.00
CURI income_statement (quarterly, 2025-12-31) — EBIT: -3372000.00
CURI income_statement (annual, 2025-12-31) — EBITDA: 7371000.00
CURI income_statement (quarterly, 2025-12-31) — EBITDA: 485000.00
CURI income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -180000.00
CURI income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 51000.00
CURI cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 180000.00
CURI cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -51000.00
CURI cash_flow (annual, 2025-12-31) — End Cash Position: 18378000.00
CURI cash_flow (quarterly, 2025-12-31) — End Cash Position: 18378000.00
CURI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -25778000.00
CURI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -5991000.00
CURI cash_flow (annual, 2025-12-31) — Free Cash Flow: 12955000.00
CURI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 3944000.00
CURI cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -88000.00
CURI cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CURI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 88000.00
CURI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 0.00
CURI income_statement (annual, 2025-12-31) — General And Administrative Expense: 33821000.00
CURI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 10611000.00
CURI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 31000000.00
CURI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 31000000.00
CURI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 9093000.00
CURI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 9093000.00
CURI balance_sheet (annual, 2025-12-31) — Gross PPE: 4885000.00
CURI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4885000.00
CURI income_statement (annual, 2025-12-31) — Gross Profit: 40545000.00
CURI income_statement (quarterly, 2025-12-31) — Gross Profit: 11616000.00
CURI balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 0.00
CURI balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 0.00
CURI income_statement (annual, 2025-12-31) — Interest Income: 983000.00
CURI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 983000.00
CURI balance_sheet (annual, 2025-12-31) — Invested Capital: 41487000.00
CURI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 41487000.00
CURI cash_flow (annual, 2025-12-31) — Investing Cash Flow: 23148000.00
CURI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 6232000.00
CURI balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 0.00
CURI balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 0.00
CURI balance_sheet (annual, 2025-12-31) — Investments And Advances: 3668000.00
CURI balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 3668000.00
CURI balance_sheet (annual, 2025-12-31) — Leases: 703000.00
CURI balance_sheet (quarterly, 2025-12-31) — Leases: 703000.00
CURI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3460000.00
CURI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3460000.00
CURI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3460000.00
CURI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3460000.00
CURI balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 3668000.00
CURI balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 3668000.00
CURI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 477000.00
CURI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 477000.00
CURI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CURI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CURI income_statement (annual, 2025-12-31) — Net Income: -6427000.00
CURI income_statement (quarterly, 2025-12-31) — Net Income: -3786000.00
CURI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -6427000.00
CURI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3786000.00
CURI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -6427000.00
CURI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3786000.00
CURI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -6427000.00
CURI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3786000.00
CURI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -6427000.00
CURI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3786000.00
CURI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -6427000.00
CURI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3786000.00
CURI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -6427000.00
CURI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3786000.00
CURI income_statement (annual, 2025-12-31) — Net Interest Income: 983000.00
CURI income_statement (quarterly, 2025-12-31) — Net Interest Income: -157000.00
CURI cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 23250000.00
CURI cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 6257000.00
CURI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 983000.00
CURI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -157000.00
CURI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -3768000.00
CURI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1292000.00
CURI balance_sheet (annual, 2025-12-31) — Net PPE: 3167000.00
CURI balance_sheet (quarterly, 2025-12-31) — Net PPE: 3167000.00
CURI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -102000.00
CURI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -25000.00
CURI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 10487000.00
CURI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 10487000.00
CURI income_statement (annual, 2025-12-31) — Normalized EBITDA: 7283000.00
CURI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 485000.00
CURI income_statement (annual, 2025-12-31) — Normalized Income: -6496520.00
CURI income_statement (quarterly, 2025-12-31) — Normalized Income: -3786000.00
CURI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 13057000.00
CURI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 3969000.00
CURI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 92000.00
CURI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -51000.00
CURI income_statement (annual, 2025-12-31) — Operating Income: -7304000.00
CURI income_statement (quarterly, 2025-12-31) — Operating Income: -3372000.00
CURI income_statement (annual, 2025-12-31) — Operating Revenue: 71658000.00
CURI income_statement (quarterly, 2025-12-31) — Operating Revenue: 20313000.00
CURI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 58734110.00
CURI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 58734110.00
CURI balance_sheet (annual, 2025-12-31) — Other Current Assets: 1198000.00
CURI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1198000.00
CURI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1423000.00
CURI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1423000.00
CURI income_statement (annual, 2025-12-31) — Other Gand A: 33821000.00
CURI income_statement (quarterly, 2025-12-31) — Other Gand A: 28501000.00
CURI income_statement (annual, 2025-12-31) — Other Income Expense: -92000.00